Article Data

  • Views 1475
  • Dowloads 153

Original Research

Open Access

Occurrence of seizures in hospitalized patients with a pre-existing seizure disorder


1,Department of Anesthesiology Mayo Clinic

DOI: 10.22514/SV72.102012.4 Vol.7,Issue 2,October 2012 pp.21-28

Published: 29 October 2012

*Corresponding Author(s): ADAM D. NIESEN E-mail:


Objective. To assess the frequency of seizures in hospitalized patients with a pre-existing seizure disorder.

Patients and Methods. A retrospective review was conducted on all patients with a documented seizure disorder who were hospitalized between January 1, 2002 and December 31, 2007. Children aged < 2 years and hospital admission for seizure control or surgical or obstetric indications were excluded. The first hospital admission of at least 24 hours was identified for each patient. Patient demographics, details of the seizure disorder, details of the hospital admission, and clinically-apparent seizure activity documented during the inpatient stay were recorded from the medical record.

Results. During the 6-year study period, 720 patients with a documented seizure disorder were admitted for at least 24 hours. Thirty-nine patients experienced seizure activity for an overall frequency of 5.4% (95% CI: 3.8-7.1%). Younger age (p = 0.001), greater frequency of baseline seizure activity (p < 0.001), recent seizure activity (p < 0.001), greater number of chronic antiepileptic medications (p = 0.01), and admission for neurological (p = 0.03) conditions were associated with increased frequency of seizure activity during hospitalization.

Conclusions. The majority of seizures occurring in hospitalized patients with a pre-existing seizure disorder appear related to the patient’s underlying seizure disorder. Because patients with frequent seizures on numerous anti-epileptic medications are likely to experience a seizure while hospitalized, it is essential to be prepared to treat seizure activity regardless of the reason for admission.


seizure disorder, hospi-talization, anticonvulsants 

Cite and Share

ADAM D. NIESEN,ADAM K. JACOB,JARED P. BRICKSON,JOHN C. FERNAU,MARVIN J. HOBBS,DEVIN S. SPENCE,SANDRA L. KOPP. Occurrence of seizures in hospitalized patients with a pre-existing seizure disorder. Signa Vitae. 2012. 7(2);21-28.


1. Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence after a 1st unprovoked seizure: An extended follow-up. Neurology 1990;40(8):1163-70.

2. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993 May-Jun;34(3):453-68.

3. Delanty N, Vaughan CJ, French JA. Medical causes of seizures. Lancet 1998;352(9125):383-90.

4. Paul F, Veauthier C, Fritz G, Lehmann TN, Aktas O, Zipp F, et al. Perioperative fluctuations of lamotrigine serum levels in patients undergoing epilepsy surgery. Seizure 2007 Sep;16(6):479-84.

5. Specht U, Elsner H, May TW, Schimichowski B, Thorbecke R. Postictal serum levels of antiepileptic drugs for detection of noncompliance. Epilepsy Behav 2003 Oct;4(5):487-95.

6. Tan JH, Wilder-Smith E, Lim ECH, Ong BKC. Frequency of provocative factors in epileptic patients admitted for seizures: A prospective study in Singapore. Seizure 2005;14(7):464-9.

7. Tatum IV WO. Antiepileptic drugs: Adverse effects and drug interactions. CONTINUUM Lifelong Learning in Neurology. 2010;16(3):136-58.

8. Niesen AD, Jacob AK, Aho LE, Botten EJ, Nase KE, Nelson JM, et al. Perioperative seizures in patients with a history of a seizure disorder. Anesth Analg 2010;111(3):729-35.

9. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996 Jun;71(6):576-86.

10. Kopp SL, Wynd KP, Horlocker TT, Hebl JR, Wilson JL. Regional blockade in patients with a history of a seizure disorder. Anesthesia and Analgesia 2009;109(1):272-8.

11. Benish SM, Cascino GD, Warner ME, Worrell GA, Wass CT. Effect of general anesthesia in patients with epilepsy: A population-based study. Epilepsy Behav 2009;17(1):87-9.

12. Akavipat P, Rungreungvanich M, Lekprasert V, Srisawasdi S. The Thai Anesthesia Incidents Study (THAI Study) of perioperative convulsion. J Med Assoc Thai 2005;88(SUPPL.7):S106-12.

13. Sokic D, Ristic AJ, Vojvodic N, Jankovic S, Sindjelic AR. Frequency, causes and phenomenology of late seizure recurrence in patients with juvenile myoclonic epilepsy after a long period of remission. Seizure 2007 Sep;16(6):533-7.

14. Barton G, Hicks E, Patterson VH, Swallow MW, Bush A, Finnegean JA, et al. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet 1991;337(8751):1175-80.

15. Brorson LO, Wranne L. Long-term prognosis in childhood epilepsy: Survival and seizure prognosis. Epilepsia 1987;28(4):324-30.

16. Forsgren L, Hauser WA, Olafsson E, Sander JWAS, Sillanpää M, Tomson T. Mortality of epilepsy in developed countries: A review. Epilepsia 2005;46(SUPPL. 11):18-27.

17. Ren WH. Anesthetic management of epileptic pediatric patients. Int Anesthesiol Clin 2009;47(3):101-16.

18. Carrera E, Claassen J, Oddo M, Emerson RG, Mayer SA, Hirsch LJ. Continuous electroencephalographic monitoring in critically Ill patients with central nervous system infections. Arch of Neurol 2008;65(12):1612-8.

19. Friedman D, Claassen J, Hirsch LJ. Continuous electroencephalogram monitoring in the intensive care unit. Anesth Analg 2009;109(2):506-23.

20. LaRoche SM. Seizures and encephalopathy. Semin Neurol 2011;31(2):194-201.

21. Vespa P. Continuous EEG monitoring for the detection of seizures in traumatic brain injury, infarction, and intracerebral hemorrhage: "To detect and protect". J Clin Neurophysiol 2005;22(2):99-106.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time